EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Carbapenem-Resistant Gram-Negative Bacteria: Mechanisms, Pathogen-Specific Strategies

Xiangquan Li iD, Xing Tang, Huafeng Ding iD, Jiaqiong Li

Infection and Drug Resistance · 2026-10 · Volume 19 · 1-18

DOI: 10.2147/idr.s630483 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Infection and Drug Resistance, 2026-10. Verfasst von Xiangquan Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

aztreonam-avibactamcarbapenem-resistant gram-negative bacteriacarbapenemaseceftazidime-avibactamcolistinimipenem-relebactammeropenem-vaborbactam

Autor:innen und Institutionen

  • Intensive Care Unit, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, People's Republic of China.
  • Intensive Care Unit, The Xuzhou Clinical College, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.

ORCID-Profile: Xiangquan Li, Huafeng Ding

Zitieren

APA

Li, X., Tang, X., Ding, H., & Li, J. (2026). Carbapenem-Resistant Gram-Negative Bacteria: Mechanisms, Pathogen-Specific Strategies. Infection and Drug Resistance, Volume 19, 1-18. https://doi.org/10.2147/idr.s630483

Vancouver

Li X, Tang X, Ding H, Li J. Carbapenem-Resistant Gram-Negative Bacteria: Mechanisms, Pathogen-Specific Strategies. Infection and Drug Resistance. 2026;Volume 19:1-18. doi:10.2147/idr.s630483

BibTeX
@article{Li2026,
  author = {Li, Xiangquan and Tang, Xing and Ding, Huafeng and Li, Jiaqiong},
  title = {Carbapenem-Resistant Gram-Negative Bacteria: Mechanisms, Pathogen-Specific Strategies},
  journal = {Infection and Drug Resistance},
  year = {2026},
  volume = {Volume 19},
  pages = {1--18},
  doi = {10.2147/idr.s630483}
}
Kostenlos starten →